JVLCX | VIVIX | JVLCX / VIVIX | |
Total Expense Ratio | 1.71 | 0.04 | 4,275% |
Annual Report Gross Expense Ratio | 1.72 | 0.04 | 4,300% |
Fund Existence | 17 years | 27 years | - |
Gain YTD | 7.822 | 6.215 | 126% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18.1B | 189B | 10% |
Annual Yield % from dividends | 0.02 | 2.19 | 1% |
Returns for 1 year | -1.26 | 12.05 | -10% |
Returns for 3 years | 14.19 | 35.17 | 40% |
Returns for 5 years | 39.89 | 80.14 | 50% |
Returns for 10 years | 26.32 | 115.68 | 23% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ROBT | 49.17 | 0.70 | +1.44% |
FT Nasdaq Artfcl Intllgnc and Rbtc ETF | |||
INRO | 29.33 | 0.30 | +1.04% |
iShares U.S. Industry Rotation Act ETF | |||
IHI | 62.30 | 0.14 | +0.23% |
iShares US Medical Devices ETF | |||
ABNY | 11.74 | 0.01 | +0.11% |
YieldMax ABNB Option Income Strategy ETF | |||
BSJU | 26.02 | N/A | N/A |
Invesco BulletShares 2030 HY Corp Bd ETF |